EGFR and lung carcinoma: Yang A analyzed a total of 1,001 lung cancer retrospectively, and showed that the HR of VTE occurrence is 2.808 (95% CI: 1.439–5.479, p = 0.002) in patients with EGFR-TKI treatment relative to patients without the treatment (25).